Literature DB >> 10506100

Cancer initiation by polycyclic aromatic hydrocarbons results from formation of stable DNA adducts rather than apurinic sites.

V J Melendez-Colon1, A Luch, A Seidel, W M Baird.   

Abstract

Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environmental pollutants with high carcinogenic potencies that have been linked to the etiology of human cancers through their presence in cigarette smoke and environmental mixtures. They are metabolically activated in cells by cytochrome P450 enzymes and/or peroxidases to reactive intermediates that damage DNA. One pathway of activation forms dihydrodiol epoxides that covalently bind to exocyclic amino groups of purines in DNA to form stable adducts. Another pathway involves formation of radical cations that bind to the N7 or C8 of purines to form unstable adducts that depurinate to leave apurinic (AP) sites in DNA. In the present study the proportions of stable DNA adducts and AP sites formed by the carcinogenic PAHs dibenzo[a,l]-pyrene (DB[a,l]P), 7,12-dimethylbenz[a]anthracene (DMBA), and benzo[a]pyrene (B[a]P) have been investigated in a target tissue for carcinogenesis, mouse epidermis. After topical application of the PAHs on the skin of female SENCAR mice epidermal DNA was isolated and the formation of stable DNA adducts was measured by (33)P-postlabeling and HPLC analysis. AP sites in DNA were measured with an aldehyde reactive probe in a slot-blot assay. At both 4 and 24 h after exposure, DB[a,l]P formed significantly higher amounts of stable DNA adducts than DMBA, and B[a]P exhibited the lowest level of binding. In contrast, the number of AP sites present in mice treated with these PAHs was in the order: DMBA > B[a]P >> DB[a,l]P. The level of AP sites was significantly lower than the level of stable adducts for each PAH. The most potent carcinogen, DB[a,l]P, induced the highest level of stable adducts and the lowest level of AP sites in epidermal DNA. These results indicate that stable DNA adducts rather than AP sites are responsible for tumor initiation by carcinogenic PAHs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10506100     DOI: 10.1093/carcin/20.10.1885

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  26 in total

Review 1.  Polycyclic aromatic hydrocarbon-DNA adduct formation in prostate carcinogenesis.

Authors:  Benjamin A Rybicki; Nora L Nock; Adnan T Savera; Deliang Tang; Andrew Rundle
Journal:  Cancer Lett       Date:  2005-09-09       Impact factor: 8.679

2.  Cytochrome P450 1b1 in polycyclic aromatic hydrocarbon (PAH)-induced skin carcinogenesis: Tumorigenicity of individual PAHs and coal-tar extract, DNA adduction and expression of select genes in the Cyp1b1 knockout mouse.

Authors:  Lisbeth K Siddens; Kristi L Bunde; Tod A Harper; Tammie J McQuistan; Christiane V Löhr; Lisa M Bramer; Katrina M Waters; Susan C Tilton; Sharon K Krueger; David E Williams; William M Baird
Journal:  Toxicol Appl Pharmacol       Date:  2015-06-03       Impact factor: 4.219

3.  Identification and quantification of DNA adducts in the oral tissues of mice treated with the environmental carcinogen dibenzo[a,l]pyrene by HPLC-MS/MS.

Authors:  Shang-Min Zhang; Kun-Ming Chen; Cesar Aliaga; Yuan-Wan Sun; Jyh-Ming Lin; Arun K Sharma; Shantu Amin; Karam El-Bayoumy
Journal:  Chem Res Toxicol       Date:  2011-07-19       Impact factor: 3.739

4.  Low-dose synergistic immunosuppression of T-dependent antibody responses by polycyclic aromatic hydrocarbons and arsenic in C57BL/6J murine spleen cells.

Authors:  Qian Li; Fredine T Lauer; Ke Jian Liu; Laurie G Hudson; Scott W Burchiel
Journal:  Toxicol Appl Pharmacol       Date:  2010-03-28       Impact factor: 4.219

Review 5.  Mode of action-based risk assessment of genotoxic carcinogens.

Authors:  Andrea Hartwig; Michael Arand; Bernd Epe; Sabine Guth; Gunnar Jahnke; Alfonso Lampen; Hans-Jörg Martus; Bernhard Monien; Ivonne M C M Rietjens; Simone Schmitz-Spanke; Gerlinde Schriever-Schwemmer; Pablo Steinberg; Gerhard Eisenbrand
Journal:  Arch Toxicol       Date:  2020-06-15       Impact factor: 5.153

6.  Active smoking and risk of Luminal and Basal-like breast cancer subtypes in the Carolina Breast Cancer Study.

Authors:  Eboneé N Butler; Chiu-Kit Tse; Mary Elizabeth Bell; Kathleen Conway; Andrew F Olshan; Melissa A Troester
Journal:  Cancer Causes Control       Date:  2016-05-06       Impact factor: 2.506

7.  Synthesis of 13C2-Benzo[a]pyrene and its 7,8-Dihydrodiol and 7,8-Dione Implicated as Carcinogenic Metabolites.

Authors:  Chongzhao Ran; Daiwang Xu; Qing Dai; Trevor M Penning; Ian A Blair; Ronald G Harvey
Journal:  Tetrahedron Lett       Date:  2008-07-21       Impact factor: 2.415

8.  Dibenzo[def,p]chrysene transplacental carcinogenesis in wild-type, Cyp1b1 knockout, and CYP1B1 humanized mice.

Authors:  Erin P Madeen; Christiane V Löhr; Hannah You; Lisbeth K Siddens; Sharon K Krueger; Roderick H Dashwood; Frank J Gonzalez; William M Baird; Emily Ho; Lisa Bramer; Katrina M Waters; David E Williams
Journal:  Mol Carcinog       Date:  2016-03-17       Impact factor: 4.784

9.  Genotoxicity-related chemistry of human metabolites of benzo[ghi]perylene (B[ghi]P) investigated using electro-optical arrays and DNA/microsome biocolloid reactors with LC-MS/MS.

Authors:  Shenmin Pan; Dandan Li; Linlin Zhao; John B Schenkman; James F Rusling
Journal:  Chem Res Toxicol       Date:  2013-08-08       Impact factor: 3.739

10.  Benzo(a)pyrene-caused increased G1-S transition requires the activation of c-Jun through p53-dependent PI-3K/Akt/ERK pathway in human embryo lung fibroblasts.

Authors:  Shi Jiao; Bingci Liu; Ai Gao; Meng Ye; Xiaowei Jia; Fengmei Zhang; Haifeng Liu; Xianglin Shi; Chuanshu Huang
Journal:  Toxicol Lett       Date:  2008-03-27       Impact factor: 4.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.